|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,100 KRW | +21.27% |
|
+26.56% | +3.04% |
| 16/05 | Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 18/03 | Kukje Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Kukje Pharma Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was KRW 37,533.87 million compared to KRW 32,407.72 million a year ago. Net income was KRW 2,749.01 million compared to KRW 833.31 million a year ago.
Basic earnings per share from continuing operations was KRW 135 compared to KRW 41 a year ago. Basic earnings per share was KRW 135 compared to KRW 41 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.04% | 89.43M | |
| +20.76% | 43.54B | |
| +18.62% | 21.51B | |
| +18.29% | 15.34B | |
| +26.36% | 15.12B | |
| +56.55% | 13.37B | |
| -0.05% | 6.79B | |
| -14.94% | 6.38B | |
| -8.87% | 5.73B | |
| +8.17% | 5.36B |
KUKJE PHARMA CO., LTD. 
